NEW YORK, April 20, 2016 -- Hudson Global, Inc. (Nasdaq:HSON), a leading global talent solutions company, will issue its first quarter financial results for the period ended March 31, 2016 at 7 a.m. ET on Thursday, April 28, 2016.
The company will host an analyst conference call to review its results, market trends and outlook at 10 a.m. ET the same day. The call will be webcast live on the investor relations section of the company’s web site, Hudson.com. The archived call will be available on the investor relations section of the company's web site, Hudson.com.
About Hudson
Hudson is a global talent solutions company with expertise in leadership and specialized recruitment, recruitment process outsourcing, talent management and contracting solutions. We help our clients and candidates succeed by leveraging our expertise, deep industry and market knowledge, and proprietary assessment tools and techniques. Operating around the globe through relationships with millions of specialized professionals, we bring an unparalleled ability to match talent with opportunities by assessing, recruiting, developing and engaging the best and brightest people for our clients. We combine broad geographic presence, world-class talent solutions and a tailored, consultative approach to help businesses and professionals achieve higher performance and outstanding results. More information is available at Hudson.com.
Contact: David F. Kirby Hudson 212-351-7216 [email protected]


Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 



